Pfizer Inc. (ETR:PFE)
Germany
· Delayed Price · Currency is EUR | Market Cap | 122.68B |
| Revenue (ttm) | 57.67B |
| Net Income (ttm) | 7.28B |
| Shares Out | n/a |
| EPS (ttm) | 1.28 |
| PE Ratio | 16.86 |
| Forward PE | 8.92 |
| Dividend | 1.57 (7.29%) |
| Ex-Dividend Date | May 9, 2025 |
| Volume | 9,474 |
| Average Volume | 46,725 |
| Open | 21.55 |
| Previous Close | 21.63 |
| Day's Range | 21.49 - 21.58 |
| 52-Week Range | 18.57 - 29.50 |
| Beta | 0.49 |
| RSI | 63.54 |
| Earnings Date | Aug 5, 2025 |
About Pfizer
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr... [Read more]
Financial Performance
In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.
Financial numbers in USD Financial StatementsNews
Recent Report Shows That Sen. Ron L Wyden Sold Up to $15K Worth of Pfizer Stock
On July 2, 2025, it was reported that Senator Ron L Wyden executed a sale of Pfizer (NYSE: PFE) stock, valued between $1,001 and $15,000. The transaction, recorded in the July filing, was made on Jun...
Pfizer: Options Activity Speaks Bullish
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Is Pfizer Stock a Yield Trap?
If AstraZeneca goes to the US it will be a major blow for London and Labour
Move would deprive LSE of its biggest star and could topple a key pillar of the government’s industrial strategy Three years ago Pascal Soriot received the ultimate accolade for turning around AstraZe...
Pfizer ends phase 2 trial for lymphoma drug from Trillium acquisition
Cannabis Lighting Market Report 2025-2030 | Share Analysis, Industry Trends & Statistics, Growth Forecasts - Pfizer Ventures into Cannabis with $6.7 Billion Deal, Boosting Industry Growth
The Cannabis Lighting Market is set to grow at a CAGR of 7.6% during the forecast period, driven by rising medical cannabis use and cultivation. Key players like Pfizer are entering the market. LED li...
House committee subpoenas Pfizer executive in probe of alleged COVID vaccine delay, CNN reports
The House Judiciary Committee has subpoenaed a former Pfizer executive who is considered central to its investigation into an allegation that clinical testing related to the company's COVID-19 vaccine...
XtalPi and Pfizer Expand Strategic Collaboration to Advance AI-Driven Drug Discovery and Materials Science Simulations
CAMBRIDGE, Mass. , June 29, 2025 /PRNewswire/ -- XtalPi (2228.HK), a leading global technology company in integrating artificial intelligence (AI) and robotics to advance the discovery of groundbreaki...
Pfizer hemophilia therapy succeeds in late-stage trial
Pfizer's bleeding disorder therapy meets main goal in patients with certain antibodies
Pfizer said on Thursday its hemophilia therapy, Hympavzi, met the main goal of a late-stage study in patients with certain types of antibodies.
Pfizer Announces Positive Topline Phase 3 Results for HYMPAVZI in Hemophilia A or B with Inhibitors
Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 BASIS study (NCT03938792) evaluating HYMPAVZI (marstacimab) for adults and adolescents living with hemophilia A or B w...
Pfizer Announces Positive Topline Phase 3 Results for HYMPAVZI™ in Hemophilia A or B with Inhibitors
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 BASIS study (NCT03938792) evaluating HYMPAVZI™ (marstacimab) for adults and adolescents liv...
Heads up: Far-right lawmakers look to table no confidence vote against EU's von der Leyen
For some context, Pfizergate refers to the supposed scandal involving EU president von der Leyen and Pfizer itself over the procurement of Covid-19 vaccines in 2021. It is mainly about the lack of tra...
Ursula von der Leyen faces no-confidence vote over Pfizergate
Far-right motion relating to pandemic scandal threatens to derail European Commission president’s second-term agenda
Pfizer Could Be The Turnaround Story In The Pharmaceutical Space
Pfizer declares $0.43 dividend
Pfizer Declares Third-Quarter 2025 Dividend
Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.43 third-quarter 2025 dividend on the company’s common stock, payable September 2, 2025, to holders of the Common Stoc...
Pfizer Declares Third-Quarter 2025 Dividend
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.43 third-quarter 2025 dividend on the company's common stock, payable September 2, 2025, to...
Don't Sleep On Pfizer: The Turnaround Is Just Getting Started
17 Ideal 'Safer' Dividend Dogs To Buy Out Of 72 June Graham Value All-Stars
I use YCharts' Value Score and Ben Graham Formula Value All Stars, or GASV, to identify large-cap stocks offering strong value and dividend safety. Seventeen out of twenty-four "safer" lowest-priced D...
Top stock price forecast: Plug Power, Uber, and Pfizer
The US stock market bounced back on Tuesday after the truce between Iran and Israel. The Dow Jones, Nasdaq 100, and S&P 500 indices jumped by over 1%, and the bullish momentum continued in the futures...
Pfizer Invites Public to View and Listen to Webcast of August 5 Conference Call with Analysts
Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:00 a.m. EDT on Tuesday, August 5, 2025. The purpose...
Pfizer Invites Public to View and Listen to Webcast of August 5 Conference Call with Analysts
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:00 a.m. EDT on Tuesday, ...